Subscribe to RSS
DOI: 10.1055/a-2734-3124
Research Design Concerns in a TriNetX Analysis of Venous Thromboembolism in Pediatric Cystic Fibrosis Patients
Authors
Dear Editor,
We enjoyed reading Trocchia et al's[1] recently published TriNetX-based study of pediatric cystic fibrosis (CF) patients. The authors found significant associations between venous thromboembolism (VTE) and an increased risk of various gastrointestinal disorders. While TriNetX allows users to analyze large amounts of aggregate patient data,[2] there is a risk of research design oversights when utilizing the automated analysis tools on the platform.[3] In this letter, we analyze some potential limitations of the Trocchia et al study.
Publication History
Received: 13 October 2025
Accepted: 29 October 2025
Accepted Manuscript online:
30 October 2025
Article published online:
10 November 2025
© 2025. Thieme. All rights reserved.
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
-
References
- 1 Trocchia C, Ashour D, Mosha M. et al. Venous thromboembolism occurrence and association with gastrointestinal disorders in children with cystic fibrosis: an analysis from the TriNetX research network global multicenter real-world dataset. Semin Thromb Hemost 2025; 51 (07) 736-744
- 2 Palchuk MB, London JW, Perez-Rey D. et al. A global federated real-world data and analytics platform for research. JAMIA Open 2023; 6 (02) ooad035
- 3 Hsieh CA, Wang J. TriNetX methodology concerns in a retrospective study of sodium-glucose cotransporter-2 inhibitors in transthyretin amyloid cardiomyopathy. Am J Cardiol 2025; 256: 16-17
- 4 Wang M, Hou TC, Wang J. Age filtering in a TriNetX-based study of pediatric rickets. J Pediatr Orthop B 2025; 34 (06) 617-618
- 5 Ley D, Turck D. Digestive outcomes in cystic fibrosis. Best Pract Res Clin Gastroenterol 2022; 56-57: 101788